Rigaku and Emerald Bio Create Strategic Alliance
Rigaku (The Woodlands, Texas) has acquired the crystallization reagent and consumables business, including crystallization screening kits, from Emerald Bio (Bainbridge Island, Washington). The companies have agreed to work together to develop new products and solutions for the field of protein science.
Rigaku (The Woodlands, Texas) has acquired the crystallization reagent and consumables business, including crystallization screening kits, from Emerald Bio (Bainbridge Island, Washington). The companies have agreed to work together to develop new products and solutions for the field of protein science.
“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” said Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division. “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”
“Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for Emerald,” said Johan Pontin, CEO of Emerald Bio.
AI-Powered SERS Spectroscopy Breakthrough Boosts Safety of Medicinal Food Products
April 16th 2025A new deep learning-enhanced spectroscopic platform—SERSome—developed by researchers in China and Finland, identifies medicinal and edible homologs (MEHs) with 98% accuracy. This innovation could revolutionize safety and quality control in the growing MEH market.
New Raman Spectroscopy Method Enhances Real-Time Monitoring Across Fermentation Processes
April 15th 2025Researchers at Delft University of Technology have developed a novel method using single compound spectra to enhance the transferability and accuracy of Raman spectroscopy models for real-time fermentation monitoring.
